FCN2
FCN2 (ficolin 2, also known as ficolin-2, P35, FCNL and EBP-37) is a calcium-dependent lectin that acts as a pattern recognition receptor. It recognises carbohydrates on pathogen surfaces and initiates the lectin pathway of the complement system. Browse Assay Genie's current range of FCN2 research reagents below, or read on for the biology behind the target.
FCN2 is a calcium-dependent lectin that functions as a pattern recognition receptor in innate immunity. It specifically recognises and binds carbohydrates on the surface of pathogens, and this binding activates the MASP1 serine protease. Activation starts the proteolytic cascade of the lectin complement pathway, which leads to phagocytosis and breakdown of pathogens and to signalling that strengthens the adaptive immune system. The FCN2 protein binds N-acetylglucosamine (GlcNAc), as well as phosphocholine and lipoteichoic acid moieties on pathogen surfaces. It also enhances phagocytosis of S. typhimurium by neutrophils, which suggests an opsonic effect.
FCN2 belongs to the ficolin lectin family. Members of this family share a leader peptide, a short N-terminal segment, a collagen-like region and a C-terminal fibrinogen-like domain. The FCN2 gene is predominantly expressed in the liver, and its product has been shown to have carbohydrate-binding and opsonic activities. The protein is found as a secreted form and at the cell surface. Alternatively spliced transcript variants encoding different isoforms have been identified. Mouse and rat both have an Fcn2 ortholog.
HGNC classifies the FCN2 gene within the fibrinogen C domain containing group, the complement system activation components and the ficolin family. Earlier names include ficolin (collagen/fibrinogen domain-containing lectin) 2, also called hucolin. Other family members include FCN1 and FCN3, which are useful comparators when studying how ficolins contribute to complement activation and pathogen recognition.
FCN2 initiates the lectin pathway by binding pathogen carbohydrates and activating the MASP1 serine protease, making it a key entry point for the cascade.
As a pattern recognition receptor, FCN2 binds GlcNAc, phosphocholine and lipoteichoic acid on pathogen surfaces, supporting studies of non-self detection.
FCN2 enhances phagocytosis of S. typhimurium by neutrophils, suggesting an opsonic effect that researchers can examine in host-pathogen models.
The FCN2 gene is predominantly expressed in the liver, which makes it relevant to studies of hepatic production of secreted immune proteins.
FCN2 is a calcium-dependent lectin and pattern recognition receptor. It binds carbohydrates on pathogen surfaces, including GlcNAc, phosphocholine and lipoteichoic acid, and activates MASP1 to start the lectin complement pathway. It also shows an opsonic effect, enhancing neutrophil phagocytosis of S. typhimurium.
FCN2 is also known as ficolin-2, P35, FCNL and EBP-37. Earlier HGNC names include ficolin (collagen/fibrinogen domain-containing lectin) 2 and hucolin. NCBI Gene reports alternatively spliced transcript variants that encode different isoforms of the protein.
Mouse and rat both carry an Fcn2 ortholog. In humans FCN2 sits in the ficolin family with FCN1 and FCN3, which share a collagen-like region and a C-terminal fibrinogen-like domain. Check the datasheet of any product for its validated reactivity.
Other ficolin family members that share the collagen-like and fibrinogen-like domain architecture and act in complement and innate immunity.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15485; product specifications from Assay Genie datasheets.